A detailed history of Concourse Financial Group Securities, Inc. transactions in Moderna, Inc. stock. As of the latest transaction made, Concourse Financial Group Securities, Inc. holds 650 shares of MRNA stock, worth $24,862. This represents 0.0% of its overall portfolio holdings.

Number of Shares
650
Previous 801 18.85%
Holding current value
$24,862
Previous $95,000 54.74%
% of portfolio
0.0%
Previous 0.01%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 10, 2024

SELL
$63.64 - $125.14 $9,609 - $18,896
-151 Reduced 18.85%
650 $43,000
Q2 2024

Jul 23, 2024

BUY
$101.21 - $166.61 $202 - $333
2 Added 0.25%
801 $95,000
Q1 2024

Apr 30, 2024

BUY
$85.37 - $115.44 $2,134 - $2,886
25 Added 3.23%
799 $85,000
Q4 2023

Feb 07, 2024

SELL
$69.51 - $104.43 $1,390 - $2,088
-20 Reduced 2.52%
774 $76,000
Q3 2023

Oct 25, 2023

SELL
$96.41 - $126.61 $13,111 - $17,218
-136 Reduced 14.62%
794 $82,000
Q2 2023

Aug 10, 2023

BUY
$118.5 - $160.53 $20,856 - $28,253
176 Added 23.34%
930 $112,000
Q1 2023

May 15, 2023

SELL
$135.66 - $197.02 $8,953 - $13,003
-66 Reduced 8.05%
754 $115,000
Q4 2022

Jan 30, 2023

SELL
$118.38 - $210.04 $1,065 - $1,890
-9 Reduced 1.09%
820 $0
Q3 2022

Nov 15, 2022

BUY
$118.07 - $194.18 $39,435 - $64,856
334 Added 67.47%
829 $98,000
Q2 2022

Aug 09, 2022

SELL
$117.13 - $176.59 $6,090 - $9,182
-52 Reduced 9.51%
495 $71,000
Q1 2022

May 09, 2022

SELL
$126.46 - $235.05 $57,412 - $106,712
-454 Reduced 45.35%
547 $94,000
Q4 2021

Feb 07, 2022

SELL
$225.82 - $368.51 $13,097 - $21,373
-58 Reduced 5.48%
1,001 $254,000
Q3 2021

Nov 09, 2021

SELL
$221.9 - $484.47 $51,702 - $112,881
-233 Reduced 18.03%
1,059 $408,000
Q2 2021

Aug 13, 2021

BUY
$129.91 - $234.98 $17,667 - $31,957
136 Added 11.76%
1,292 $303,000
Q1 2021

May 13, 2021

BUY
$109.18 - $185.98 $2,620 - $4,463
24 Added 2.12%
1,156 $151,000
Q4 2020

Feb 02, 2021

BUY
$65.74 - $169.86 $26,098 - $67,434
397 Added 54.01%
1,132 $118,000
Q3 2020

Nov 13, 2020

BUY
$54.34 - $94.85 $7,770 - $13,563
143 Added 24.16%
735 $52,000
Q2 2020

Aug 13, 2020

BUY
$29.67 - $80.0 $17,564 - $47,360
592 New
592 $38,000
Q1 2020

May 13, 2020

BUY
$17.78 - $31.58 $0 - $0
0 New
0 $0
Q4 2019

Feb 14, 2020

BUY
$13.93 - $21.28 $0 - $0
0 New
0 $0
Q3 2019

Nov 13, 2019

BUY
$12.26 - $18.07 $0 - $0
0 New
0 $0
Q2 2019

Aug 13, 2019

BUY
$13.7 - $28.34 $0 - $0
0 New
0 $0
Q1 2019

May 15, 2019

BUY
$14.45 - $23.7 $0 - $0
0 New
0 $0
Q4 2018

Feb 14, 2019

BUY
$13.52 - $18.8 $0 - $0
0 New
0 $0

Others Institutions Holding MRNA

About Moderna, Inc.


  • Ticker MRNA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 391,200,000
  • Market Cap $15B
  • Description
  • Moderna, Inc., a biotechnology company, discovers, develops, and commercializes messenger RNA therapeutics and vaccines for the treatment of infectious diseases, immuno-oncology, rare diseases, cardiovascular diseases, and auto-immune diseases in the United States, Europe, and internationally. Its respiratory vaccines include COVID-19, flu, resp...
More about MRNA
Track This Portfolio

Track Concourse Financial Group Securities, Inc. Portfolio

Follow Concourse Financial Group Securities, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Concourse Financial Group Securities, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Concourse Financial Group Securities, Inc. with notifications on news.